FDA — authorised 31 July 2000
- Application: NDA021178
- Marketing authorisation holder: BRISTOL MYERS SQUIBB
- Local brand name: GLUCOVANCE
- Indication: TABLET — ORAL
- Status: approved
FDA authorised Glucovance on 31 July 2000
Yes. FDA authorised it on 31 July 2000.
BRISTOL MYERS SQUIBB holds the US marketing authorisation.